Fundz

BIOCAPTIVA raises £1.5 million in a funding round to drive international growth. The round is led by experienced executives aiming to enhance the company's cancer liquid biopsy technology's commercial adoption.

PRIVATEAug 16, 2026

Amount Raised

£1.5 Million

Round Type

Seed

EdinburghHealth Care

Description

University of Edinburgh spin-out BIOCAPTIVA has secured £1.5 million in a recent funding round to accelerate international growth. The firm has recently launched its cancer liquid biopsy technology platform and received ISO 13485 certification. The new capital will help expand its impact across cfDNA sequencing applications. Experienced life sciences executive Stephane Argivier has been appointed as the new chair.

Quick answer

BIOCAPTIVA raised £1.5 Million in a Seed round, dated August 16, 2026. BIOCAPTIVA is based in Edinburgh, Scotland, United Kingdom.

How much did BIOCAPTIVA raise?
BIOCAPTIVA raised £1.5 Million in a Seed round on August 16, 2026.
What does BIOCAPTIVA do?
BIOCAPTIVA is developing the BioCaptis, a revolutionary medical device which has the potential to transform liquid biopsy testing for cancer management, by improving early diagnosis and monitoring of disease and..
Where is BIOCAPTIVA based and how big is it?
BIOCAPTIVA is based in Edinburgh, Scotland, United Kingdom. Fundz records about 2 employees.
Who are the decision-makers at BIOCAPTIVA?
Fundz holds 2 contacts at BIOCAPTIVA, including the Chief Technology Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Health Care around the same time

Companies in the same sectors as BIOCAPTIVA that raised within 45 days of this round, from Fundz verified event records.

  • Prodoc AI raised an undisclosed amount (Seed) on September 30, 2026.
  • R1 Therapeutics raised $81M (Series A) on September 30, 2026.
  • Blue Health Intelligence raised $3.9M (Seed) on September 30, 2026.
  • AnaCardio raised $71M (Series B) on September 30, 2026.
  • Vytalyou raised $939K (Pre-Series A) on September 30, 2026.
  • Aleph Surgical raised $7.5M (Pre-Seed) on September 30, 2026.

Who to call at BIOCAPTIVA, and when

A new round usually means BIOCAPTIVA is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day BIOCAPTIVA raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at BIOCAPTIVA, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at BIOCAPTIVA. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

BIOCAPTIVA

Location

Edinburgh, Scotland, United Kingdom

About

BIOCAPTIVA is developing the BioCaptis, a revolutionary medical device which has the potential to transform liquid biopsy testing for cancer management, by improving early diagnosis and monitoring of disease and enhancing clinical trial data of cancer patients. The BioCaptis captures up to 100x more cell free DNA (cfDNA) than a venous blood draw, yielding cfDNA in high quality and quantity for testing, addressing the major challenge of liquid biopsy in cancer management. This will potentially allow the testing of a far greater number of cancer types and stages in a much wider range of patients. BIOCAPTIVA was founded in 2021 when it spun out from the University of Edinburgh. BIOCAPTIVA is based in Edinburgh and backed by Archangels Scottish Enterprise, Cancer Research Horizons, the new innovation engine of Cancer Research UK and Old College Capital, the University of Edinburgh's in-house venture investment fund. For more information, please visit www.biocaptiva.com and follow us on LinkedIn

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment BIOCAPTIVA raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsAlan S., Chief Technology Officer hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for BIOCAPTIVA's next move

See what Strategic adds

BIOCAPTIVA raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.